Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Clinical Studies, Single and Multiple-Dose Safety and Pharmaco-261025025
University of Michigan (INC)
Search grants from University of Michigan (INC)
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
MR Imaging of the Excitatory and Inhibitory Neurotransmitters in Chronic Pain
Functional Effects of Adenosine A2A Receptor Activation on Microglia
Translational Research in Polycystic Ovary Syndrome
Large-scale analysis of Candida albicans gene function
Sexual Risk Reduction Among Men with Mental Illness
Recently added grants:
Shared Resource 10: Medicinal Chemistry (MCSR)
Shared Resource 11: Microscopy (MSR)
Shared Resource 12: Nutrient and Phytochemical Analytics (NPASR)
Shared Resource 13: Pharmaco Analytical (PhASR)
Shared Resource 14: Proteomics (PSR)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025025-002
Application #
6828861
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
University of Michigan (INC)
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I Clinical Studies, Single and Multiple-Dose Safety and Pharmaco-261025025
/ University of Michigan (INC)
NIH 2002
N01 CA
Phase I Clinical Studies, Single and Multiple-Dose Safety and Pharmaco-261025025
/ University of Michigan (INC)
Comments
Be the first to comment on this grant